These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 20577605)

  • 1. Predictors of PSA Screening Among Men Over 40 Years of Age Who Had Ever Heard about PSA.
    Seo HS; Lee NK
    Korean J Urol; 2010 Jun; 51(6):391-7. PubMed ID: 20577605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Demographics and health-related factors of men receiving prostate-specific antigen screening in Utah.
    Merrill RM
    Prev Med; 2001 Dec; 33(6):646-52. PubMed ID: 11716662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlates of prostate-specific antigen testing in a large multiethnic cohort.
    Haque R; Van Den Eeden SK; Jacobsen SJ; Caan B; Avila CC; Slezak J; Sternfeld B; Loo RK; Quinn VP
    Am J Manag Care; 2009 Nov; 15(11):793-9. PubMed ID: 19895183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavioral associations between prostate and colon cancer screening.
    Carlos RC; Underwood W; Fendrick AM; Bernstein SJ
    J Am Coll Surg; 2005 Feb; 200(2):216-23. PubMed ID: 15664097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of prostate cancer screening among health fair participants.
    Chiu BC; Anderson JR; Corbin D
    Public Health; 2005 Aug; 119(8):686-93. PubMed ID: 15949522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of obesity and lower serum prostate-specific antigen levels on prostate-cancer screening results in American men.
    Culp S; Porter M
    BJU Int; 2009 Nov; 104(10):1457-61. PubMed ID: 19522868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lifetime and recent prostate specific antigen (PSA) screening of men for prostate cancer in Canada.
    Beaulac JA; Fry RN; Onysko J
    Can J Public Health; 2006; 97(3):171-6. PubMed ID: 16827400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate cancer screening decision-making in three states: 2013 behavioral risk factor surveillance system analysis.
    Li J; Hall IJ; Zhao G
    Cancer Causes Control; 2017 Mar; 28(3):235-240. PubMed ID: 28210882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonlinear Relationship Between Age and Likelihood of Undergoing Prostate-Specific Antigen Testing, and the Predictive Factors of Testing at Different Ages.
    He H; Liu T; Zhao F; Feng X; Lyu J; Gao Y
    Am J Mens Health; 2021; 15(3):15579883211026515. PubMed ID: 34167355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sociodemographic and health status characteristics with prostate cancer screening in a national cohort of middle-aged male veterans.
    Eisen SA; Waterman B; Skinner CS; Scherrer JF; Romeis JC; Bucholz K; Heath A; Goldberg J; Lyons MJ; Tsuang MT; True WR
    Urology; 1999 Mar; 53(3):516-22. PubMed ID: 10096377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ever and Annual Use of Prostate Cancer Screening in African American Men.
    Halbert CH; Gattoni-Celli S; Savage S; Prasad SM; Kittles R; Briggs V; Delmoor E; Rice LJ; Jefferson M; Johnson JC
    Am J Mens Health; 2017 Jan; 11(1):99-107. PubMed ID: 26240090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of child-bearing intentions of low-income women: attitudes versus life circumstances.
    Radecki SE; Beckman LJ
    J Biosoc Sci; 1992 Apr; 24(2):157-66. PubMed ID: 1583030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of prostate-specific antigen for prostate cancer screening in primary care practice.
    Williams RB; Boles M; Johnson RE
    Arch Fam Med; 1995 Apr; 4(4):311-5. PubMed ID: 7536091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minority issues in prostate disease.
    French DB; Jones LA
    Med Clin North Am; 2005 Jul; 89(4):805-16. PubMed ID: 15925651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The association between physician trust and prostate-specific antigen screening: Implications for shared decision-making.
    Klaassen Z; Wallis CJD; Goldberg H; Chandrasekar T; Fleshner NE; Finelli A; Kulkarni GS; Detsky AS; Satkunasivam R
    Can Urol Assoc J; 2018 Dec; 12(12):395-400. PubMed ID: 29940136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surveillance for certain health behaviors among states and selected local areas - United States, 2008.
    Hughes E; Kilmer G; Li Y; Valluru B; Brown J; Colclough G; Geathers S; Roberts H; Elam-Evans L; Balluz L;
    MMWR Surveill Summ; 2010 Dec; 59(10):1-221. PubMed ID: 21150869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for Prostate Cancer: US Preventive Services Task Force Recommendation Statement.
    ; Grossman DC; Curry SJ; Owens DK; Bibbins-Domingo K; Caughey AB; Davidson KW; Doubeni CA; Ebell M; Epling JW; Kemper AR; Krist AH; Kubik M; Landefeld CS; Mangione CM; Silverstein M; Simon MA; Siu AL; Tseng CW
    JAMA; 2018 May; 319(18):1901-1913. PubMed ID: 29801017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate cancer screening practices in a large, integrated health system: 2007-2014.
    Misra-Hebert AD; Hu B; Klein EA; Stephenson A; Taksler GB; Kattan MW; Rothberg MB
    BJU Int; 2017 Aug; 120(2):257-264. PubMed ID: 28139034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and predictors of cancer screening among American Indian and Alaska native people: the EARTH study.
    Schumacher MC; Slattery ML; Lanier AP; Ma KN; Edwards S; Ferucci ED; Tom-Orme L
    Cancer Causes Control; 2008 Sep; 19(7):725-37. PubMed ID: 18307048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. State-by-state Variation in Prostate-specific Antigen Screening Trends Following the 2011 United States Preventive Services Task Force Panel Update.
    Vetterlein MW; Dalela D; Sammon JD; Karabon P; Sood A; Jindal T; Meyer CP; Löppenberg B; Sun M; Trinh QD; Menon M; Abdollah F
    Urology; 2018 Feb; 112():56-65. PubMed ID: 29056579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.